
ICU Medical ICUI
$ 121.01
-1.5%
Annual report 2025
added 02-19-2026
ICU Medical Interest Expense 2011-2026 | ICUI
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense ICU Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93.3 M | 107 M | 103 M | 70.8 M | 858 K | 1.75 M | 549 K | 709 K | 2.05 M | 118 K | 39 K | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 107 M | 39 K | 34.5 M |
Quarterly Interest Expense ICU Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.8 M | 20.5 M | 22 M | - | 24.7 M | 23.8 M | 23.8 M | - | 24.2 M | 24.1 M | 22.5 M | - | 17.8 M | 15.4 M | 13.6 M | - | 168 K | 163 K | 161 K | - | 616 K | 771 K | 967 K | - | 139 K | 139 K | 133 K | - | 283 K | 130 K | 135 K | - | 705 K | 525 K | 513 K | - | 58 K | 48 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 24.7 M | 48 K | 8.9 M |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M | ||
|
Alcon
ALC
|
204 M | $ 75.4 | -0.8 % | $ 40.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
-26 K | $ 11.21 | -1.41 % | $ 27.2 M | ||
|
The Cooper Companies
COO
|
-16.4 M | $ 63.09 | -1.94 % | $ 12.6 B | ||
|
iRhythm Technologies
IRTC
|
5.44 M | $ 125.44 | -0.41 % | $ 4.01 B | ||
|
Haemonetics Corporation
HAE
|
-9.75 M | $ 59.84 | -1.06 % | $ 3.01 B | ||
|
electroCore
ECOR
|
14.9 K | $ 6.15 | 1.32 % | $ 52.2 K | ||
|
Repro Med Systems
KRMD
|
9.91 K | $ 4.08 | 0.49 % | $ 188 M | ||
|
Isoray
ISR
|
2 K | - | 0.03 % | $ 108 M | ||
|
Microbot Medical
MBOT
|
2 K | $ 2.1 | -3.23 % | $ 96.2 M | ||
|
Glaukos Corporation
GKOS
|
13.6 M | $ 119.63 | -2.0 % | $ 5.79 B | ||
|
Milestone Scientific
MLSS
|
126 K | $ 0.33 | -4.15 % | $ 27.1 M | ||
|
Masimo Corporation
MASI
|
300 K | $ 178.51 | -0.08 % | $ 9.51 B | ||
|
InfuSystem Holdings
INFU
|
1.4 M | $ 10.18 | -4.5 % | $ 210 M | ||
|
Merit Medical Systems
MMSI
|
-2.39 M | $ 66.74 | -1.02 % | $ 3.95 B | ||
|
Envista Holdings Corporation
NVST
|
-2.3 M | $ 26.49 | -1.05 % | $ 4.45 B | ||
|
Pulse Biosciences
PLSE
|
-52 K | $ 21.83 | -3.62 % | $ 1.47 B | ||
|
Retractable Technologies
RVP
|
227 K | $ 0.62 | -2.99 % | $ 18.6 M | ||
|
Pro-Dex
PDEX
|
533 K | $ 51.51 | -0.87 % | $ 169 M | ||
|
LeMaitre Vascular
LMAT
|
5.18 M | $ 112.4 | -1.85 % | $ 2.54 B | ||
|
STAAR Surgical Company
STAA
|
2.25 M | $ 26.7 | 0.07 % | $ 1.32 B | ||
|
STERIS plc
STE
|
8.4 M | $ 219.75 | -1.1 % | $ 21.7 B | ||
|
Predictive Oncology
POAI
|
3 | - | - | $ 31.1 M | ||
|
Teleflex Incorporated
TFX
|
57 M | $ 135.52 | 0.33 % | $ 6.05 B | ||
|
BioLife Solutions
BLFS
|
497 K | $ 20.9 | -2.38 % | $ 963 M | ||
|
Stereotaxis
STXS
|
2 K | $ 1.86 | -3.63 % | $ 169 M | ||
|
Baxter International
BAX
|
290 M | $ 17.94 | -2.97 % | $ 9.2 B | ||
|
ResMed
RMD
|
3.2 M | $ 217.14 | -2.2 % | $ 31.7 B | ||
|
AtriCure
ATRC
|
683 K | $ 28.48 | -1.93 % | $ 1.36 B | ||
|
Utah Medical Products
UTMD
|
-120 K | $ 66.61 | -0.25 % | $ 216 M | ||
|
Harvard Bioscience
HBIO
|
-2.66 M | $ 6.45 | -5.56 % | $ 286 M | ||
|
West Pharmaceutical Services
WST
|
-1 M | $ 292.13 | -3.33 % | $ 21.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
24 M | $ 11.78 | -1.51 % | $ 2.35 B | ||
|
AngioDynamics
ANGO
|
4.94 M | $ 10.98 | -0.99 % | $ 449 M | ||
|
Becton, Dickinson and Company
BDX
|
613 M | $ 149.52 | -0.47 % | $ 43 B | ||
|
Nephros
NEPH
|
2 K | $ 3.32 | 2.79 % | $ 34.5 M | ||
|
OraSure Technologies
OSUR
|
229 K | $ 3.01 | - | $ 221 M | ||
|
Repligen Corporation
RGEN
|
8.12 M | $ 117.43 | -0.73 % | $ 6.54 M |